|
Market Closed -
Nasdaq
23:00:00 06/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 7.500 USD | -2.98% |
|
-12.38% | -28.57% |
| 10-02 | Nanobiotix Names New Finance Chief | MT |
| 10-01 | Nanobiotix Appoints Arnd Christ as CFO | MT |
Company Valuation: Immatics N.V.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 845.5 | 663.9 | 891.4 | 848.6 | 1,408 | 1,057 | - | - |
| Change | - | -21.47% | 34.26% | -4.8% | 65.88% | -24.94% | - | - |
| Enterprise Value (EV) 1 | 710 | 289.7 | 445.7 | 610.6 | 1,026 | 770.4 | 717.9 | 786.9 |
| Change | - | -59.19% | 53.83% | 36.99% | 68% | -24.89% | -6.82% | 9.61% |
| P/E | -8.25x | 14.7x | -8.08x | 47.1x | -5.61x | -3.66x | -3.67x | -4.19x |
| PBR | - | - | - | - | 2.51x | - | - | - |
| PEG | - | -0x | 0x | -0x | 0x | -0.3x | 8.31x | 0.3x |
| Capitalization / Revenue | 22.1x | 3.57x | 15.2x | 5.05x | 25.1x | 22.7x | 26.7x | 9.22x |
| EV / Revenue | 18.5x | 1.56x | 7.6x | 3.63x | 18.3x | 16.6x | 18.1x | 6.87x |
| EV / EBITDA | -7.96x | 7.29x | -4.34x | -21.5x | -5.2x | -2.64x | -2.22x | -2.13x |
| EV / EBIT | -7.47x | 8.99x | -4.04x | -14.7x | -4.85x | -2.47x | -2.11x | -2.45x |
| EV / FCF | -7.43x | - | -32.6x | -3.25x | -4.84x | -3.89x | -2.32x | -2.55x |
| FCF Yield | -13.5% | - | -3.06% | -30.8% | -20.7% | -25.7% | -43.2% | -39.2% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -1.63 | 0.592 | -1.303 | 0.151 | -1.872 | -2.114 | -2.104 | -1.845 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 38.29 | 186 | 58.62 | 168.1 | 56.13 | 46.54 | 39.58 | 114.6 |
| EBITDA 1 | -89.24 | 39.74 | -102.6 | -28.46 | -197.3 | -292.1 | -322.9 | -369.3 |
| EBIT 1 | -95.04 | 32.24 | -110.4 | -41.65 | -211.7 | -311.3 | -340.8 | -321 |
| Net income 1 | -102.8 | 40.38 | -105.3 | 16.41 | -228.5 | -287.4 | -309.6 | -284.9 |
| Net Debt 1 | -135.5 | -374.2 | -445.8 | -238.1 | -381.9 | -286.2 | -338.7 | -269.7 |
| Reference price 2 | 13.440 | 8.710 | 10.530 | 7.110 | 10.500 | 7.730 | 7.730 | 7.730 |
| Nbr of stocks (in thousands) | 62,909 | 76,227 | 84,656 | 119,356 | 134,064 | 136,690 | - | - |
| Announcement Date | 3/23/22 A | 3/21/23 A | 3/21/24 A | 3/27/25 A | 3/5/26 A | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.66x | 16.55x | -2.64x | -.--% | 1.06B | |
| 21.73x | 7.72x | 15.51x | 1.37% | 74.31B | |
| 29.59x | 8.5x | 26.48x | 0.04% | 56.95B | |
| 33.52x | 6.02x | 18.04x | 0.97% | 48.3B | |
| -21.51x | 223.61x | -23.09x | -.--% | 44.51B | |
| 34.27x | 3.31x | 14.29x | -.--% | 43.8B | |
| 47.24x | 5.47x | 29.99x | -.--% | 41.12B | |
| 27.63x | 7.93x | 20.48x | 0.41% | 31.07B | |
| 33.5x | 7.16x | 18.6x | -.--% | 28.97B | |
| -15.28x | 5.82x | -7.31x | -.--% | 24.53B | |
| Average | 18.70x | 29.21x | 11.03x | 0.28% | 39.46B | |
| Weighted average by Cap. | 22.44x | 31.13x | 13.57x | 0.41% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- IMTX Stock
- Valuation Immatics N.V.
Select your edition
All financial news and data tailored to specific country editions
